Optimizerx CORP Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
OPRX
Optimizerx CORPSCHEDULE 13D/A: Whetstone Capital Withdraws Board Nominations at OptimizeRx Following Agreement on Director Appointment
Whetstone Capital Advisors, a significant shareholder in OptimizeRx Corporation, has conditionally withdrawn its nominations for the company's 2025 annual meeting board election, following an agreement with OptimizeRx to appoint a new independent director.
NASDAQ
OPRX
Optimizerx CORPWhetstone Capital Advisors, holding an 8.2% stake in OptimizeRx Corporation, has formally nominated Andrew Carlson and John Fein for election to the company's Board of Directors at the upcoming 2025 annual meeting.
NASDAQ
OPRX
Optimizerx CORPWhetstone Capital Advisors and David Atterbury have disclosed an 8.2% stake in OptimizeRx Corporation, urging the company's Board of Directors to consider strategic alternatives, including a full sale, to maximize shareholder value.